1007875-64-0

Upstream product

• 869885-60-9 1-benzofuran-5-sulfonyl chloride 
• 160232-08-6 (2R,3S)-3-tert-butoxycarbonylamino-1-isobutylamino-4-phenyl-2-butanol 

Downstream Products

• 1007877-53-3 C₂₂H₂₈N₂O₄S 
• 1007876-69-8 C₂₈H₃₈N₂O₆S 
• 1007875-94-6 C₂₇H₃₆N₂O₆S 
• 1007877-56-6 C₂₃H₃₀N₂O₄S 
• 1007875-70-8 C₂₇H₃₆N₂O₆S 
• 1007877-55-5 C₂₃H₃₀N₂O₄S 
• 1007877-54-4 C₂₃H₂₈N₂O₄S 

Relevant academic research and scientific papers

KETAMINE AND CYTOCHROME P 450 INHIBITOR COMBINATIONS

Compositions and methods of treating depression infections are provided. More particularly, compositions including a combination of ketamine and a cytochrome p450 enzyme inhibitor are provided. Methods of using the compositions for treatment of depression

METHODS FOR INHIBITING DRUG DEGRADATION

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters

HIV PROTEASE INHIBITOR AND CYTOCHROME P450 INHIBITOR COMBINATIONS

Compositions and methods of treating viral infections are provided. More particularly, compositions including a combination of protease inhibitors and cytochrome p450 enzyme inhibitors are provided. Methods of using the compositions for treatment of disea

COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P450

Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Pharmaceutical compositions are provided that can act as boosters